ECM
NXTC icon

ExodusPoint Capital Management’s NextCure NXTC Stock Holding History

ExodusPoint Capital Management’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,704
Closed -$26K – 1882
2023
Q3 		$26K Sell
1,704
-852
-33% -$16.3K ﹤0.01% 1623
2023
Q2 		$55K Sell
2,556
-68
-3% -$1.34K ﹤0.01% 1772
2023
Q1 		$47K Sell
2,624
-291
-10% -$5.6K ﹤0.01% 1669
2022
Q4 		$49K Sell
2,915
-1,225
-30% -$28.2K ﹤0.01% 1547
2022
Q3 		$137K Sell
4,140
-2,763
-40% -$141K ﹤0.01% 1703
2022
Q2 		$389K Sell
6,903
-881
-11% -$46K ﹤0.01% 1442
2022
Q1 		$454K Buy
7,784
+1,009
+15% +$63.1K 0.01% 1588
2021
Q4 		$488K Buy
6,775
+5,919
+691% +$495K 0.01% 1435
2021
Q3 		$69K Sell
856
-2,621
-75% -$230K ﹤0.01% 1944
2021
Q2 		$335K Buy
3,477
+2,339
+206% +$239K ﹤0.01% 1678
2021
Q1 		$137K Buy
+1,138
New +$165K ﹤0.01% 1939
2020
Q3 		– Sell
-2,111
Closed -$543K – 2091
2020
Q2 		$543K Buy
+2,111
New +$804K 0.01% 1037

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return

ExodusPoint Capital Management's NXTC Position: Q4 2023 in Review

ExodusPoint Capital Management sold out of NextCure (NXTC) in Q4 2023, closing a stake of 1,704 shares — an estimated $26K sold.

ExodusPoint Capital Management first reported a position in NXTC in Q2 2020 and held it in 12 quarters. The position peaked at $543K in Q2 2020. 43 funds tracked by Wall St. Rank hold NXTC as of Q4 2023.

  • ExodusPoint Capital Management reported no remaining NextCure position as of Q4 2023 after selling out during the quarter.
  • ExodusPoint Capital Management sold 1,704 NextCure shares in Q4 2023, an estimated $26K.
  • ExodusPoint Capital Management first reported a position in NextCure in Q2 2020 and held it in 12 quarters.
  • ExodusPoint Capital Management's NextCure position peaked at $543K in Q2 2020.
  • 43 funds tracked by Wall St. Rank held NextCure as of Q4 2023.

Based on ExodusPoint Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.